Chronic Idiopathic Constipation

Prucalopride was safe and effective in increasing the frequency of complete spontaneous bowel movements in patients with chronic idiopathic constipation, regardless of age, BMI or renal function, according to data.

Although constipation affects millions of people worldwide, it remains one of the least discussed health concerns due to social stigma, according to a press release from the International Foundation for Gastrointestinal Disorders.

Treatment with once-daily linaclotide was well-tolerated and resulted in significant improvement in spontaneous bowel movements and stool consistency vs. placebo among children with functional constipation, researchers reported.

Throughout 2023, gastroenterology societies made several significant clinical practice updates to guide diagnosis, management and treatment of various GI disorders such as celiac disease, inflammatory bowel disease and acute liver failure.

Anthony Lembo, MD, Director of Research for Cleveland Clinic's Digestive Disease & Surgery Institute, discusses the diagnostic process for patients presenting with constipation; approaching management of patients with IBS-C and CIC; treatment options and recent therapeutic advances; health disparities; and important challenges of care.

Anthony Lembo, MD, Director of Research for Cleveland Clinic's Digestive Disease & Surgery Institute, discusses the diagnostic process for patients presenting with constipation; approaching management of patients with IBS-C and CIC; treatment options and recent therapeutic advances; health disparities; and important challenges of care.

Anthony Lembo, MD, Director of Research for Cleveland Clinic's Digestive Disease & Surgery Institute, discusses the diagnostic process for patients presenting with constipation; approaching management of patients with IBS-C and CIC; treatment options and recent therapeutic advances; health disparities; and important challenges of care.

More than half of the respondents in Salix Pharmaceutical’s annual patient perspective survey reported waiting at least a year before mentioning their irritable bowel syndrome symptoms to a health care provider.

CHARLOTTE, N.C. — Once daily plecanatide effectively relieved symptoms in patients of varying age with chronic idiopathic constipation and irritable bowel syndrome-constipation, according to a poster at the ACG Annual Scientific Meeting.

The American Gastroenterological Association recently updated its guidance for refractory celiac disease, which features a step-by-step approach for following a gluten-free diet and information on tests and treatments.